RxDoctor Payments Data

Jessica Lujan, APRN

Family · Coeur D Alene, IDNPI 1750936522

Payments from drug & device makers

$1,925in general payments, 2019–2025

Across 107 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$575
  • Corcept Therapeutics$227
  • Lilly USA, LLC$127
  • Phathom Pharmaceuticals, Inc.$91
  • Exact Sciences$84
  • Novartis$82
  • plus $738 from 20 others

What the payments were for

  • Food & beverage$1,925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,925 in reported general payments places this provider in the 80th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$20,752
Medicare patients
67
Services billed
1,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$18,176
Dexlansoprazole DrDexlansoprazole15$2,621
Liothyronine Sodium18$2,600
Levothyroxine Sodium144$1,462
Duloxetine Hcl47$1,231
Oxybutynin Chloride ErOxybutynin Chloride30$1,180
Atorvastatin Calcium84$820
SynthroidLevothyroxine Sodium13$615
Fluoxetine Hcl34$585
Irbesartan11$450
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide21$444
Lisinopril61$435
Estradiol11$409
Losartan Potassium39$389
Oxybutynin Chloride14$359

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$18,17621 claims
AbbVieSynthroid$575$61513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 809 family providers in Idaho.

Other family in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →